Philip Newland - Jones
Consultant Pharmacist in Diabetes and Endocrinology, Clinical Director of the Diabetes and Endocrine
Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and is the Clinical Director of the Diabetes and Endocrine service at University Hospitals Southampton NHS Foundation Trust. He is a member of the UKCPA Diabetes and Endocrinology Committee, the Joint British Diabetes Societies (JBDS-IP) Committee, and the Centre of Perioperative Care (CPOC) diabetes working group. At Southampton he is the clinical lead for type 1 diabetes and as an interest in severe insulin resistance. At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group, and a member of the Diabetes UK professional council. He is an editorial board member of “Diabetes in Primary Care”, the “Journal of Medicines Optimisation” and “Medicine Matters diabetes”. He is also a specialist advisor to the CQC for diabetes in secondary and intermediate care services. In 2015 he was awarded the National Leadership in Pharmacy award by the Royal Pharmaceutical Society. Philip leads a large dynamic team and is responsible for the direction of inpatient and outpatient diabetes and endocrine care at University Hospital Southampton. He works in a Consultant practitioner prescribing Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes and endocrine issues. His dedication to education ensures the rest of his time is taken up educating doctors, nurses, allied healthcare professionals and students within secondary care, primary care and university settings. He is the MSc module lead for “Modern Management of Diabetes, Nutrition and Pharmacotherapy” at the University of Southampton.